GetTopicDetailResponse(id=06ea882261, topicName=HIF-2α抑制劑, introduction=HIF-2α抑制劑, content=null, image=null, comments=0, allHits=811, url=https://h5.medsci.cn/topic?id=8822, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=37902, tagList=[TagDto(tagId=37902, tagName=HIF-2α抑制劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2252990, encodeId=a2912252990af, content=<a href='/topic/show?id=6bc382e5474' target=_blank style='color:#2F92EE;'>#腎透明細(xì)胞癌#</a> <a href='/topic/show?id=60c232154fc' target=_blank style='color:#2F92EE;'>#創(chuàng)新藥物#</a> <a href='/topic/show?id=06ea882261' target=_blank style='color:#2F92EE;'>#HIF-2α抑制劑#</a> <a href='/topic/show?id=bca6124480a4' target=_blank style='color:#2F92EE;'>#Casdatifan#</a>, objectTitle=HIF-2α抑制劑Casdatifan（AB521）治療腎透明細(xì)胞癌I期臨床數(shù)據(jù)公布，疾病控制率超80%！, objectType=article, longId=864227, objectId=5f8386422e0a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668024236648_4754896.jpeg, objectUrl=/article/show_article.do?id=5f8386422e0a, replyNumber=0, likeNumber=44, createdTime=2025-02-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=5f8386422e0a, moduleTitle=HIF-2α抑制劑Casdatifan（AB521）治療腎透明細(xì)胞癌I期臨床數(shù)據(jù)公布，疾病控制率超80%！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5f8386422e0a)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
